spacer
spacer
Go to PDB code: 
protein ligands Protein-protein interface(s) links
Isomerase PDB id
1ftx
Jmol
Contents
Protein chains
380 a.a. *
Ligands
EPC ×2
Waters ×268
* Residue conservation analysis
PDB id:
1ftx
Name: Isomerase
Title: Crystal stucture of alanine racemase in complex with d- alanine phosphonate
Structure: Alanine racemase. Chain: a, b. Engineered: yes
Source: Geobacillus stearothermophilus. Organism_taxid: 1422. Expressed in: escherichia coli. Expression_system_taxid: 562
Biol. unit: Dimer (from PQS)
Resolution:
2.20Å     R-factor:   0.183     R-free:   0.211
Authors: G.F.Stamper,D.Ringe
Key ref:
K.A.Watson et al. (1994). Design of inhibitors of glycogen phosphorylase: a study of alpha- and beta-C-glucosides and 1-thio-beta-D-glucose compounds. Biochemistry, 33, 5745-5758. PubMed id: 8180201 DOI: 10.1021/bi00185a011
Date:
13-Sep-00     Release date:   14-Jan-03    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
P10724  (ALR_GEOSE) -  Alanine racemase
Seq:
Struc:
388 a.a.
380 a.a.*
Key:    PfamA domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 1 residue position (black cross)

 Enzyme reactions 
   Enzyme class: E.C.5.1.1.1  - Alanine racemase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: L-alanine = D-alanine
L-alanine
= D-alanine
      Cofactor: Pyridoxal 5'-phosphate
Pyridoxal 5'-phosphate
Bound ligand (Het Group name = EPC) matches with 65.00% similarity
Molecule diagrams generated from .mol files obtained from the KEGG ftp site
 Gene Ontology (GO) functional annotation 
  GO annot!
  Biological process     cell wall organization   4 terms 
  Biochemical function     catalytic activity     3 terms  

 

 
    reference    
 
 
DOI no: 10.1021/bi00185a011 Biochemistry 33:5745-5758 (1994)
PubMed id: 8180201  
 
 
Design of inhibitors of glycogen phosphorylase: a study of alpha- and beta-C-glucosides and 1-thio-beta-D-glucose compounds.
K.A.Watson, E.P.Mitchell, L.N.Johnson, J.C.Son, C.J.Bichard, M.G.Orchard, G.W.Fleet, N.G.Oikonomakos, D.D.Leonidas, M.Kontou.
 
  ABSTRACT  
 
alpha-D-Glucose is a weak inhibitor of glycogen phosphorylase b (Ki = 1.7 mM) and acts as a physiological regulator of hepatic glycogen metabolism. Glucose binds to phosphorylase at the catalytic site and results in a conformational change that stabilizes the inactive T state of the enzyme, promoting the action of protein phosphatase 1 and stimulating glycogen synthase. It has been suggested that, in the liver, glucose analogues with greater affinity for glycogen phosphorylase may result in a more effective regulatory agent. Several alpha- and beta-anhydroglucoheptonic acid derivatives and 1-deoxy-1-thio-beta-D-glucose analogues have been synthesized and tested in a series of crystallographic and kinetic binding studies with glycogen phosphorylase. The structural results of the bound enzyme-ligand complexes have been analyzed, together with the resulting affinities, in an effort to understand and exploit the molecular interactions that might give rise to a better inhibitor. This work has shown the following: (i) Similar affinities may be obtained through different sets of interactions. Specifically, in the case of the alpha- and beta-glucose-C-amides, similar Ki's (0.37 and 0.44 mM, respectively) are obtained with the alpha-anomer through interactions from the ligand via water molecules to the protein and with the beta-anomer through direct interaction from the ligand to the protein. Thus, hydrogen bonds through water can contribute binding energy similar to that of hydrogen bonds directly to the protein. (ii) Attempts to improve the inhibition by additional groups did not always lead to the expected result. The addition of nonpolar groups to the alpha-carboxamide resulted in a change in conformation of the pyranose ring from a chair to a skew boat and the consequent loss of favorable hydrogen bonds and increase in the Ki. (iii) The addition of polar groups to the alpha-carboxamide led to compounds with the chair conformation, and in the examples studied, it appears that hydration by a water molecule may provide sufficient stabilization to retain the chair conformation. (iv) The best inhibitor was N-methyl-beta-glucose-C-carboxamide (Ki = 0.16 mM), which showed a 46-fold improvement in Ki from the parent beta-D-glucose. The decrease in Ki may be accounted for by a single hydrogen bond from the amide nitrogen to a main-chain carbonyl oxygen, an increase in entropy through displacement of a water molecule, and favorable van der Waals contacts between the methyl substituent and nonpolar protein residues.(ABSTRACT TRUNCATED AT 250 WORDS)
 

Literature references that cite this PDB file's key reference

  PubMed id Reference
21053051 A.K.Malde, and A.E.Mark (2011).
Challenges in the determination of the binding modes of non-standard ligands in X-ray crystal complexes.
  J Comput Aided Mol Des, 25, 1.  
18518825 L.L.Lairson, B.Henrissat, G.J.Davies, and S.G.Withers (2008).
Glycosyltransferases: structures, functions, and mechanisms.
  Annu Rev Biochem, 77, 521-555.  
16464598 T.Hadjiloi, C.Tiraidis, E.D.Chrysina, D.D.Leonidas, N.G.Oikonomakos, P.Tsipos, and T.Gimisis (2006).
Binding of oxalyl derivatives of beta-d-glucopyranosylamine to muscle glycogen phosphorylase b.
  Bioorg Med Chem, 14, 3872-3882.
PDB codes: 2f3p 2f3q 2f3s 2f3u
15741340 E.D.Chrysina, M.N.Kosmopoulou, C.Tiraidis, R.Kardakaris, N.Bischler, D.D.Leonidas, Z.Hadady, L.Somsak, T.Docsa, P.Gergely, and N.G.Oikonomakos (2005).
Kinetic and crystallographic studies on 2-(beta-D-glucopyranosyl)-5-methyl-1, 3, 4-oxadiazole, -benzothiazole, and -benzimidazole, inhibitors of muscle glycogen phosphorylase b. Evidence for a new binding site.
  Protein Sci, 14, 873-888.
PDB codes: 1xkx 1xl0 1xl1
16245298 G.Archontis, K.A.Watson, Q.Xie, G.Andreou, E.D.Chrysina, S.E.Zographos, N.G.Oikonomakos, and M.Karplus (2005).
Glycogen phosphorylase inhibitors: a free energy perturbation analysis of glucopyranose spirohydantoin analogues.
  Proteins, 61, 984-998.  
16222658 K.A.Watson, E.D.Chrysina, K.E.Tsitsanou, S.E.Zographos, G.Archontis, G.W.Fleet, and N.G.Oikonomakos (2005).
Kinetic and crystallographic studies of glucopyranose spirohydantoin and glucopyranosylamine analogs inhibitors of glycogen phosphorylase.
  Proteins, 61, 966-983.
PDB codes: 1fs4 1ftq 1ftw 1fty 1fu4 1fu7 1fu8
15858635 M.Ambrosi, N.R.Cameron, and B.G.Davis (2005).
Lectins: tools for the molecular understanding of the glycocode.
  Org Biomol Chem, 3, 1593-1608.  
11895439 N.G.Oikonomakos, M.Kosmopoulou, S.E.Zographos, D.D.Leonidas, E.D.Chrysina, L.Somsák, V.Nagy, J.P.Praly, T.Docsa, B.Tóth, and P.Gergely (2002).
Binding of N-acetyl-N '-beta-D-glucopyranosyl urea and N-benzoyl-N '-beta-D-glucopyranosyl urea to glycogen phosphorylase b: kinetic and crystallographic studies.
  Eur J Biochem, 269, 1684-1696.
PDB codes: 1k06 1k08 1k0q 1kti
11740102 A.Linden, X.Li, and C.K.Lee (2001).
Two ethyl 2-deoxy-alpha-D-hexo-3,7-pyranoso-3-octulosonate derivatives.
  Acta Crystallogr C, 57, 1418-1420.  
11227044 J.L.Treadway, P.Mendys, and D.J.Hoover (2001).
Glycogen phosphorylase inhibitors for treatment of type 2 diabetes mellitus.
  Expert Opin Investig Drugs, 10, 439-454.  
  10873856 N.G.Oikonomakos, V.T.Skamnaki, K.E.Tsitsanou, N.G.Gavalas, and L.N.Johnson (2000).
A new allosteric site in glycogen phosphorylase b as a target for drug interactions.
  Structure, 8, 575-584.
PDB code: 1c50
  10211820 K.E.Tsitsanou, N.G.Oikonomakos, S.E.Zographos, V.T.Skamnaki, M.Gregoriou, K.A.Watson, L.N.Johnson, and G.W.Fleet (1999).
Effects of commonly used cryoprotectants on glycogen phosphorylase activity and structure.
  Protein Sci, 8, 741-749.
PDB codes: 1b4d 1bx3
  9753693 E.Chung, D.Henriques, D.Renzoni, M.Zvelebil, J.M.Bradshaw, G.Waksman, C.V.Robinson, and J.E.Ladbury (1998).
Mass spectrometric and thermodynamic studies reveal the role of water molecules in complexes formed between SH2 domains and tyrosyl phosphopeptides.
  Structure, 6, 1141-1151.  
  9568898 M.Gregoriou, M.E.Noble, K.A.Watson, E.F.Garman, T.M.Krulle, C.de la Fuente, G.W.Fleet, N.G.Oikonomakos, and L.N.Johnson (1998).
The structure of a glycogen phosphorylase glucopyranose spirohydantoin complex at 1.8 A resolution and 100 K: the role of the water structure and its contribution to binding.
  Protein Sci, 7, 915-927.
PDB codes: 1a8i 2gpn
9465093 W.H.Martin, D.J.Hoover, S.J.Armento, I.A.Stock, R.K.McPherson, D.E.Danley, R.W.Stevenson, E.J.Barrett, and J.L.Treadway (1998).
Discovery of a human liver glycogen phosphorylase inhibitor that lowers blood glucose in vivo.
  Proc Natl Acad Sci U S A, 95, 1776-1781.  
8652510 E.P.Mitchell, S.G.Withers, P.Ermert, A.T.Vasella, E.F.Garman, N.G.Oikonomakos, and L.N.Johnson (1996).
Ternary complex crystal structures of glycogen phosphorylase with the transition state analogue nojirimycin tetrazole and phosphate in the T and R states.
  Biochemistry, 35, 7341-7355.
PDB codes: 1noi 1noj 1nok
  9000013 J.E.Ladbury (1996).
Just add water! The effect of water on the specificity of protein-ligand binding sites and its potential application to drug design.
  Chem Biol, 3, 973-980.  
7642613 D.Massillon, M.Bollen, H.De Wulf, K.Overloop, F.Vanstapel, P.Van Hecke, and W.Stalmans (1995).
Demonstration of a glycogen/glucose 1-phosphate cycle in hepatocytes from fasted rats. Selective inactivation of phosphorylase by 2-deoxy-2-fluoro-alpha-D-glucopyranosyl fluoride.
  J Biol Chem, 270, 19351-19356.  
7737174 M.Board, M.Hadwen, and L.N.Johnson (1995).
Effects of novel analogues of D-glucose on glycogen phosphorylase activities in crude extracts of liver and skeletal muscle.
  Eur J Biochem, 228, 753-761.  
  8580837 N.G.Oikonomakos, M.Kontou, S.E.Zographos, K.A.Watson, L.N.Johnson, C.J.Bichard, G.W.Fleet, and K.R.Acharya (1995).
N-acetyl-beta-D-glucopyranosylamine: a potent T-state inhibitor of glycogen phosphorylase. A comparison with alpha-D-glucose.
  Protein Sci, 4, 2469-2477.
PDB codes: 1prj 2prj
  7867660 N.G.Oikonomakos, M.Kontou, S.E.Zographos, H.S.Tsitoura, L.N.Johnson, K.A.Watson, E.P.Mitchell, G.W.Fleet, J.C.Son, and C.J.Bichard (1994).
The design of potential antidiabetic drugs: experimental investigation of a number of beta-D-glucose analogue inhibitors of glycogen phosphorylase.
  Eur J Drug Metab Pharmacokinet, 19, 185-192.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB codes are shown on the right.